Terumo Blood and Cell Technologies and CSL Plasma announced a collaboration to deliver a new plasma collection platform ...
ITOCHU Corporation announced on April 15, 2021, that it has made a decision to establish Hyuga Biomass Power G...
Japanese-European team of scientists, including researchers from Fujita Health University, describe mutations in the&n...
Japan's pioneering life science organizations seeking to navigate Japanese market entry gained a new pathway. Shonan Hea...
Researchers from The University of Tokyo have developed a novel device for the safe and effective long-term transplant...
US based BioCryst Pharmaceuticals, Inc. has announced that the Japanese National Health Insurance System (NHI) has appro...
Thermo Fisher Scientific Inc. has announced on April 12, 2021 that the U.S. Food and Drug Administration (FDA) has grant...
L Catterton, US based consumer-focused private equity firm, has announced an investment of JPY 20 billion into PHC ...
Remiges Ventures, a US-based cross-border venture capital firm with offices in Seattle, WA and Tokyo, Jap...
Hitachi, Ltd. and Axcelead, Inc. have announced that they have agreed on a comprehensive collaborative partnership to de...
Daiichi Sankyo, based in Japan, has announced that it has initiated in Japan a first-in-human phase 1 trial for nafamost...
Leading Japanese medical VR company Jolly Good Inc. has recently established a specialized DTx Division to develop digit...
Japan based firm FUJIFILM Wako Pure Chemical Corporation has announced the launch of the “N501Y mutation detection...
Daiichi Sankyo Company, Ltd. has announced that it will terminate its marketing alliance agreement for the Squarekids&re...
Social Welfare Organization Saiseikai Branch Tochigi Prefecture Saiseikai Utsunomiya Hospital in Utsunom...
Japanese firms KYORIN Pharmaceutical, a subsidiary of KYORIN Holdings, Inc., and Eisai Co., Ltd. have entered into a lic...
Toyoda Gosei, a Japanese manufacturer of rubber and plastic automotive components and LEDs, has invested in Genial ...
Eisai Co., Ltd. announced on March 30, 2021 that the European Medicines Agency (EMA) has confirmed it has acce...
